The interstellar comet 3I/ATLAS has shifted from a routine curiosity to a physics puzzle, as NASA and other teams report that ...

Microsoft Corporation stock is down 25% as capex fears rise. Click for this updated look at MSFT stock post earnings and see why I remain bullish.

Alphabet’s ( GOOGL) shares rose 29% during Q4 after a 38% rise in Q3. It's worth noting that the shares have more than ...

Modern steel ships warp a magnetic compass with both permanent and induced magnetism, and the binnacle is packed with clever countermeasures to cancel it out. This breaks down hard iron vs soft iron ...

The real estate industry has a new giant. Compass and Anywhere have officially merged. The companies announced the close of the $1.6 billion deal Friday morning through filings with the Securities and ...

The mega-merger between Compass and Anywhere Real Estate, the country’s two largest brokerages by deal volume, has closed. Compass announced in September it would pay $1.6 billion in stock to acquire ...

Dec 18 (Reuters) - U.S. antitrust enforcers should consider blocking a bid by Compass (COMP.N), opens new tab, the nation's largest residential real estate broker, to acquire rival Anywhere Real ...

Alfredo has a PhD in Astrophysics and a Master's in Quantum Fields and Fundamental Forces from Imperial College London. Alfredo has a PhD in Astrophysics and a Master's in Quantum Fields and ...

Compass announced a $10B all-stock acquisition of Anywhere, adding over 340,000 agents. The deal is expected to close in late 2026 but may face antitrust scrutiny and possible asset divestitures in ...

The first reports of comet 3I/ATLAS were made on July 1, 2025, by the ATLAS (Asteroid Terrestrial-impact Last Alert System) telescope in Chile. This comet caught the world's attention since it was the ...

In early July, astronomers spotted a mysterious object, later dubbed 3I/ATLAS after it was confirmed to be the third-ever interstellar visitor cruising through our solar system. Last week, the object, ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third ...